Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Menstrual Cup Maker Fails on Validations

  • Post author:Sam
  • Post published:September 11, 2020
  • Post category:The GMP Letter

Failure to validate reprocessing instructions for its Class II reusable menstrual cups and a host of other quality issues landed Dot International a seven-item Form 483 following an FDA inspection…

Continue ReadingMenstrual Cup Maker Fails on Validations

Hudson Scientific Falls Short on Process Controls

  • Post author:Sam
  • Post published:September 11, 2020
  • Post category:The GMP Letter

Process control procedures were found to be lax during an FDA inspection of Hudson Scientific’s Hudson, Michigan facility. Source: The GMP Letter

Continue ReadingHudson Scientific Falls Short on Process Controls

Duodenoscope Maker Olympus Fails to Submit MDRs

  • Post author:Sam
  • Post published:September 11, 2020
  • Post category:The GMP Letter

Failure to submit medical device reports to the FDA within the prescribed timeframe and lax complaint handling landed duodenoscope maker Olympus a Form 483 following an FDA inspection of its…

Continue ReadingDuodenoscope Maker Olympus Fails to Submit MDRs

FDA Grants EUA for Abbott’s Card-Based COVID-19 Antigen Test

  • Post author:Sam
  • Post published:September 11, 2020
  • Post category:The GMP Letter

The FDA has granted Abbott Laboratories an Emergency Use Authorization for its COVID-19 antigen test, a diagnostic that provides fast, readable results on a card similar to some pregnancy tests.…

Continue ReadingFDA Grants EUA for Abbott’s Card-Based COVID-19 Antigen Test

Tips for Upgrading Your Medical Device Recall Strategy

  • Post author:Sam
  • Post published:September 11, 2020
  • Post category:The GMP Letter

Recalls in the medical device industry are a business activity — not just something that the regulatory and quality teams do. Source: The GMP Letter

Continue ReadingTips for Upgrading Your Medical Device Recall Strategy

EU Sets Common Specifications for Reprocessing Single-Use Devices

  • Post author:Sam
  • Post published:September 11, 2020
  • Post category:The GMP Letter

The European Commission has established common specifications for reprocessing single-use devices under the EU Medical Device Regulation. Source: The GMP Letter

Continue ReadingEU Sets Common Specifications for Reprocessing Single-Use Devices

DOJ Probes Sanofi, GSK for Failure to Disclose Contaminated Zantac

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

Sanofi and GlaxoSmithKline announced in Security Exchange Commission (SEC) filings that the Department of Justice and the U.S. Attorney’s Office for the Eastern District of Pennsylvania have opened an investigation…

Continue ReadingDOJ Probes Sanofi, GSK for Failure to Disclose Contaminated Zantac

EMA Calls for Risk Evaluation for Nitrosamines in Some Biologics

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

The European Medicines Agency (EMA) has updated its advice on impurity testing for nitrosamines, expanding it to include some biological medicines. Source: Drug GMP Report

Continue ReadingEMA Calls for Risk Evaluation for Nitrosamines in Some Biologics

Most Postmark Commitments on Schedule in 2019, FDA Says

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

Drugmakers successfully completed a majority of postmarketing requirements and commitments in fiscal 2019, the FDA said in its latest annual report. Source: Drug GMP Report

Continue ReadingMost Postmark Commitments on Schedule in 2019, FDA Says

EMA Suspends Generics Tested at Mumbai Lab

  • Post author:Sam
  • Post published:September 10, 2020
  • Post category:Drug GMP Report

The European Medicines Agency’s suspended the marketing authorizations of generic drugs tested by Panexcell Clinical Laboratories at its site in Mumbai, India. Source: Drug GMP Report

Continue ReadingEMA Suspends Generics Tested at Mumbai Lab
  • Go to the previous page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.